Keyphrases
Acetylcholine Receptor Antibody
11%
AIDS/HIV
9%
Autoantibodies
7%
Autoimmune Autonomic Ganglionopathy
8%
Autonomic Dysfunction
7%
Beneficial Effects
7%
Blood Pressure
8%
Cerebellar Granule Neurons
10%
Cerebrovascular Disease
9%
Cholesterol
9%
Cholesterol-fed Rabbit
8%
Chotosan
12%
Chronic Hepatitis C
46%
Cinnamaldehyde
8%
Clinical Features
8%
Cognitive Function
8%
Combination Therapy
7%
Crude Drug
8%
Diabetic
13%
Disease Activity
8%
Dose Effect
10%
Eculizumab
10%
Endothelial Function
7%
Endothelium
11%
Endothelium-dependent Relaxation
9%
Free Radicals
16%
Galectin-3 (Gal-3)
8%
Genotype 1
7%
Glucose Intolerance
8%
Glutamate
11%
Hachimijiogan
14%
Hemorheology
11%
Hepatitis C
18%
Hepatitis C Virus
8%
Hepatocellular Carcinoma
7%
Herbal Medicine
25%
High-fat Diet
7%
Hochuekkito
10%
IL28B
8%
Immunomodulatory Effect
7%
Influenza A
9%
Inhibitory Effect
25%
Insulin Resistance
13%
Interferon-α (IFN-α)
17%
Interleukin-2
7%
Isolated Rat Aorta
16%
Japan
27%
Japanese Kampo Medicine
15%
Kampo
49%
Kampo Formula
27%
Kampo Medicine
65%
Keishibukuryogan
56%
Killer Cell Immunoglobulin-like Receptor
10%
Kyushu
11%
Lipid Peroxides
9%
Liver
9%
Liver Injury
10%
Lymphocyte Transformation Test
10%
Lysis
13%
Macrophages
10%
Metabolic Syndrome
22%
Monosodium Glutamate
11%
Mouse Model
20%
Myasthenia Gravis
14%
Natural Killer Cells
9%
Neuronal Death
17%
Nicotinic Acetylcholine Receptor (nAChR)
9%
Non-alcoholic Fatty Liver Disease (NAFLD)
20%
Nonalcoholic Steatohepatitis
20%
Obesity
12%
Oketsu
14%
Okinawa
10%
Oral Administration
11%
Paeoniae Radix Alba
8%
Pegylated Interferon
15%
Peripheral Lymphocytes
9%
Placebo
7%
Placebo-controlled
8%
Population-based Study
11%
Protective Effect
28%
Red Blood Cells
13%
Rheumatoid Arthritis
26%
Rheumatoid Arthritis Patients
10%
Ribavirin
15%
Ribavirin Treatment
13%
Scutellariae Radix
8%
SHRSP
8%
Spontaneously Hypertensive Rats
9%
Steatohepatitis
8%
Sustained Virological Response
19%
Telaprevir
8%
Tokishakuyakusan
8%
Traditional Japanese Medicine
23%
Traditional Medicine
14%
Triple Therapy
8%
Uncaria Sinensis
18%
Vascular Function
10%
Vasodilator
14%
Virological Response
9%
Virus
10%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
9%
Alzheimer's Disease
7%
Antioxidant
10%
Antivirus Agent
11%
Atherosclerosis
7%
Biological Marker
7%
Blood Stasis
5%
Bu Zhong Yi Qi Tang
7%
Cerebrovascular Disease
8%
Cholinergic Receptor Antibody
6%
Chronic Hepatitis C
44%
Cinnamaldehyde
8%
Clinical Study
7%
Combination Therapy
7%
Controlled Clinical Trial
5%
Coughing
6%
Creatinine
5%
Crude Drug
8%
Curcuma
5%
Cytokine
6%
Diabetes Mellitus
9%
Diabetic Retinopathy
5%
Disease
22%
Eculizumab
8%
Escherichia Coli Infection
5%
Fibrinogen
5%
Free Radical
16%
Galectin 3
8%
Gerbil
7%
Glutamate Sodium
5%
Glutamic Acid
12%
Guinea Pig
5%
Hachimijiogan
10%
Hepatitis C Virus
13%
HIV
6%
Hydroxyl Radical
5%
Hyperlipidemia
9%
Hypoxia Inducible Factor 1
5%
Infection
7%
Inflammation
5%
Inflammatory Arthritis
9%
Influenza A
8%
Insulin Dependent Diabetes Mellitus
5%
Insulin Resistance
8%
Interferon
17%
Ischemia
8%
Kampo Medicine (Drug)
100%
Keishi Bukuryo Gan
52%
Kidney Injury
7%
Leporidae
14%
Lipid Peroxide
6%
Liver Cell Carcinoma
9%
Liver Injury
18%
Medicinal Plant
6%
Messenger RNA
11%
Metabolic Syndrome X
19%
Methanol
5%
Mixed Infection
5%
Mouse Model
19%
Multiinfarct Dementia
8%
Myasthenia gravis
9%
Neoplasm
5%
Nitric Oxide
8%
Nitric Oxide Donor
5%
Nonalcoholic Fatty Liver
27%
Ob/Ob Mouse
5%
Observational Study
5%
Orengedoku to
5%
Peginterferon
16%
Placebo
13%
Plasma Protein
5%
Population Study
8%
Procyanidin
5%
Radix Paeoniae
10%
Randomized Controlled Trial
5%
Reactive Oxygen Metabolite
6%
Rheumatoid Arthritis
9%
Rhubarb
5%
Ribavirin
17%
Scutellariae Radix
6%
Spontaneously Hypertensive Rat
7%
Stroke Prone Spontaneously Hypertensive Rat
7%
Superoxide
7%
Syndrome
10%
Telaprevir
8%
Toxic Hepatitis
6%
Triacylglycerol
10%
Triterpene
5%
Tumor Necrosis Factor
10%
Uncaria
24%
Vasodilator Agent
8%
Virus RNA
6%
Viscum Album Extract
6%
Medicine and Dentistry
Adenoma
5%
Adverse Event
6%
Alzheimer's Disease
7%
Antiviral Therapy
5%
Arthritis
5%
Balloon Occlusion
5%
Blood Pressure
5%
Body Mass Index
5%
CD8 Antigen
5%
Cholinergic Receptor Antibody
6%
Chronic Hepatitis C
27%
Clinical Feature
6%
Clinical Trial
5%
Cognition
5%
Combination Therapy
5%
Diabetes
6%
Diabetes Mellitus
5%
Diagnosis
8%
Disease
14%
Drug Therapy
5%
Endoscopic Hemostasis
5%
Erythrocyte
10%
False Positive Result
5%
Free Radical
10%
Galectin 3
5%
Gene Expression
6%
Glutamate Sodium
10%
Hachimijiogan
10%
Hepatitis
5%
Hepatitis C Virus
9%
Hepatocellular Carcinoma
9%
Homeopathy
23%
Human Immunodeficiency Virus
6%
Hyperlipidemia
7%
Hypoxia Inducible Factor 1
5%
In Vitro
8%
Infection
5%
Inflammatory Arthritis
8%
Ingestion
5%
Insulin Dependent Diabetes Mellitus
5%
Interferon
10%
Kampo
78%
Keishi Bukuryo Gan
33%
Kidney Injury
7%
Liver Injury
17%
Lymphocyte Subpopulation
5%
Lymphocyte Transformation
10%
Macrophage
5%
Medicine
6%
Messenger RNA
5%
Metabolic Syndrome
8%
Nonalcoholic Fatty Liver
26%
Peginterferon
9%
Placebo
7%
Polyp
9%
Population Research
8%
Radix Paeoniae
7%
Rheumatoid Arthritis
8%
Ribavirin
9%
Spontaneously Hypertensive Rat
6%
Steatohepatitis
9%
Tongue
8%
Toxic Hepatitis
6%
Traditional Medicine
10%
Triterpene
5%
Urinary System
6%